MIAMI, March 30, 2011 (GLOBE NEWSWIRE) -- BioZone Pharmaceuticals, Inc. (OTCBB:BZNE) announced today that it closed a $2.25 million bridge financing. The Company previously announced that it recently entered into $2.25 million of Secured Purchase Agreements for issuance of 10% secured promissory bridge notes due August 24, 2011. In connection with the sale of the bridge notes, the Company also entered into a Registration Rights Agreement, a Pledge and Security Agreement and issued warrants.
